Viewing nowCombinationAlbit Tablet
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Korea PMG Pharmaceutical Co., Ltd.

MFDS item code 201405006 · Approved 2014.10.29
This product's status changed to Expired on 2024.10.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.) and prevention of Mendelson's syndrome
This medication is used for the treatment of ulcers in the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps in the prevention of postoperative ulcers and treats gastric and duodenal ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). It is administered before anesthesia to prevent Mendelson's syndrome. This medication regulates gastric acid secretion, protects the gastric mucosa, and is effective in alleviating symptoms. It is widely used for the treatment and prevention of gastrointestinal diseases.
○ Adults Usually, administer 2 tablets per dose orally 2 times daily, regardless of meals, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets per dose 2 times daily, or 4 tablets per dose once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose 2 times daily, in the morning and at bedtime. The same dose applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose 2 times daily for 8 weeks, or 4 tablets per dose once daily at bedtime. However, the dose may be increased to 4 tablets per dose 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose 2 times daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets per dose on the night before surgery.
This medication should not be used in patients undergoing dialysis or those with impaired kidney function. Additionally, patients who have had allergic reactions to this medication or its ingredients, those with a history of acute porphyria, patients who have had upper gastrointestinal surgery, pregnant women or women who may become pregnant, premature infants or neonates, and patients on a potassium-restricted diet should also avoid it. Patients with poor liver function, those who have previously had drug allergies, elderly patients, those with kidney problems, and those taking NSAIDs should use this medication cautiously. Particularly, this medication can mask symptoms of gastric cancer, so patients with gastric ulcers or those over middle age who have recently developed dyspepsia should use it only after confirming the malignancy. Patients with Helicobacter pylori in gastric or duodenal ulcers should receive eradication therapy simultaneously, and severe patients in intensive care, patients with hypophosphatemia, and those who have difficulty swallowing also need to exercise caution. Rarely, serious allergic reactions such as anaphylactic shock may occur while using this medication, so if symptoms arise, administration should be stopped immediately and appropriate treatment sought. Hypersensitivity reactions such as skin rash, hives, angioedema, fever, and bronchospasm may also occur, and if these symptoms appear, the medication should be discontinued. Regular testing is required as blood tests may show decreased white blood cells, platelets, or liver function abnormalities. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and the stool may turn black, although this does not require special treatment. In severe and elderly patients, dizziness, drowsiness, confusion, depression, and hallucinations may occur infrequently, so caution is advised. Myalgia or arthralgia may occur, and in severe cases, rhabdomyolysis can occur, so if there are any unusual symptoms, medical personnel should be informed immediately. This medication should not be taken long-term and should be used in the minimum dose while carefully monitoring the treatment process. Elderly patients or those with chronic pulmonary diseases or diabetes may have an increased risk of pneumonia while taking this medication. If dizziness or drowsiness occurs while taking this medication, driving or operating hazardous machinery should be avoided. There may be interactions with other medications, so especially when taking anticoagulants or certain antibiotics or analgesics, consultation with healthcare providers is essential. It is safest for pregnant or breastfeeding women not to use this medication, and safety in children has not been established, so it is not recommended for pediatric use. In case of overdose, treatments such as vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis may be helpful. Finally, this medication can reduce gastric acid secretion and promote bacterial growth in the stomach, so regular check-ups, including eye examinations, are necessary for long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air ingress, and it is best stored at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication and prevent degradation.
Round white film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Korea PMG Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.